A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: Controlled study versus placebo

Fundamental and Clinical Pharmacology

Volumn 11, Issue 2, 1997, Pages 127-132

  Bourin, M ^a   Bougerol, T ^b   Guitton, B ^a   Broutin, E ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c Laboratoires Soekami Lefrancq   (France)

Author keywords

anxious mood; herbal therapy

Indexed keywords

BALLOTA EXTRACT; PASSIFLORA INCARNATA EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; VALERIAN;

ADJUSTMENT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRATAEGUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MEDICINAL PLANT; MOOD; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTPATIENT; PHYTOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030887771     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00179.x     Document Type: Article

References (27)

1. Angst J, Wollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand 1991;84:446-52
2. Aron C, Simon P, Larousse C, Boissier JR. Evaluation of a rapid technique detecting minor tranquillizers. Neuropharmacology 1971;10:459-69
3. Ashton M. Risk of dependence on benzodiazepine drugs: a major problem of long term treatment. Br Med J 1989;298: 103-4
4. Barlow DH, Blanchard EB, DiNardo PA, Vermileya JA, Vermileya BB. Generalized anxiety and generalized anxiety disorder: description and reconceptualization. Am J Psychiatry 1986;143:40-4
5. Bech P. Rating Scales for Psychopathology. Health Status and Quality of Life. Berlin Heidelberg: Springer-Verlag, 1993
6. Bennati E. Identification by thin layer chromatography of liquid extract of Passiflora incarnata. Boll Chim Farm 1967;106: 756-60
7. Bennati E, Fedeli E. Gas chromatography of fluid extract of Passiflora incarnata. Boll Chim Farm 1968;107:716-20
8. Bourin M. Étude des effets de l'Euphytose sur les performances psychométriques du volontaire sain. Psychol Med 1994;26: 1471-8
9. Bourin M, Malinge M. Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:567-75
10. Bourin M, Couëtoux du Tertre A, Payeur R. Evaluation of safety and side effects in the process of anti-anxiety drug development. Eur Psychiatry 1993;8:285-91
11. Breier A, Charnen DS, Heninger GR. The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 1985;142:787-96
12. Covi L, Lipman MC, Nair DM, Crezlinsky T. Symptomatic volunteers in multicenter drug trials. Progr Neuropsychopharmacol Biol Psychiatry 1979;3:521-8
13. Curran HV. Benzodiazepines memory and mood: a review. Psychopharmacology 1991;105:1-8
14. Foerster W, Becker H, Rodriguez E. HPLC analysis and valepotriates in the North American Genera Plectritis and Valeriana. Planta Med 1984;1:7-9
15. Gerhard U, Linnenbrink N, Georghiadon C, Hobi V. Vigilance-reducing effects of two herbal hypnotics. Schweiz Rundsch Med Prax 1996;85:473-81
16. Guelfi JD, Pull CB, Guelfi C, Ruschel S, Dreyfus JF. La CHESS. Utilisation dans la pathologie anxieuse et dépressive. Structure factorielle. Ann Med Psychol 1983;141:257-77
17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5
18. Herman AR. Pharmacological properties of Paullinia cupana. J Ethnopharmacol 1982;6:311-38
19. Lader M. Diagnosis and treatment of generalized anxiety disorder in current therapeutic approaches to panic and other anxiety disorders. In: Darcourt G, Mendlewicz J, Racagni G, Brunello N, eds. International Academy for Biomedical and Drug Research. 1994;8:113-20
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiat 1979;134:382-9
21. Murphy SM, Owen R, Tyrer P. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone. Br J Psychiatry 1989;154:528-34
22. Schatzberg AF. Anxiety and adjustment disorder. A treatment approach. J Clin Psychiatr 1990;51(suppl 11):20-4
23. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(suppl 3): 89-95
24. Tueth MJ. Anxiety in the older patient: differential diagnosis and treatment. Geriatrics 1993;48:51-4
25. Tyrer P. Risk of dependence on benzodiazepine drugs. The importance of patient selection. Br Med J 1989;298: 104-5
26. Valli M, Paubert-Braquet M, Pilot S, Fabre R, Lefrançois G, Rod D. Euphytose, an association of plant extracts with anxiolytic activity: investigation of its mechanism of action by an in vitro binding study. Phytother Res 1991;5:241-4
27. Von Eicksted KW, Rahman S. Psychopharmacologic effects of valepotriates. Arzneimittelforsch 1969;19:316-9